FITCHBURG, Mass.--(BUSINESS WIRE)--Arrhythmia Research Technology, Inc. (the “Company”) (AMEX:HRT) and its wholly owned subsidiary, Micron Products, Inc. (“Micron”) reported total consolidated revenue of $19,318,000 for the year ended December 31, 2006 compared to total consolidated revenue of $12,895,000 for the year ended December 31, 2005, an increase of 50%. Net income of $2,164,000 for the year ended December 31, 2006 increased 37% from net income of $1,578,000 for the year ended December 31, 2005. Basic net income per share for the year ended December 31, 2006 increased 37% to $0.81 per share from $0.59 per share for 2005.
